{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:35:37Z","timestamp":1761100537210,"version":"3.30.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,7,1]]},"DOI":"10.1038\/sj.bmt.1702445","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:42:19Z","timestamp":1031154139000},"page":"45-50","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma"],"prefix":"10.1038","volume":"26","author":[{"given":"MA","family":"Gertz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MQ","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DJ","family":"Inwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DA","family":"Gastineau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MG","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TE","family":"Witzig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PR","family":"Greipp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MR","family":"Litzow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,7,7]]},"reference":[{"key":"BF1702445_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM et al. for the Intergroupe Fran\u00e7ais du Myelome A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma New Engl J Med 1996 335: 91\u201397","journal-title":"New Engl J Med"},{"key":"BF1702445_CR2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V89.3.789","volume":"89","author":"B Barlogie","year":"1997","unstructured":"Barlogie B, Jagannath S, Vesole DH et al. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma Blood 1997 89: 789\u2013793","journal-title":"Blood"},{"key":"BF1702445_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/sj.bmt.1700867","volume":"20","author":"A Alegre","year":"1997","unstructured":"Alegre A, Tomas JF, Martinez-Chamorrow C et al. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone Bone Marrow Transplant 1997 20: 211\u2013217","journal-title":"Bone Marrow Transplant"},{"key":"BF1702445_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/sj.bmt.1701062","volume":"21","author":"A Alegre","year":"1998","unstructured":"Alegre A, Diaz-Mediavilla J, San-Miguel J et al. for the Spanish Registry for Transplant in MM (Grupo Espanol de Trasplante Hematopoyetico-GETH) and PETHEMA Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry Bone Marrow Transplant 1998 21: 133\u2013140","journal-title":"Bone Marrow Transplant"},{"key":"BF1702445_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/stem.5530130204","volume":"13","author":"YW Huang","year":"1995","unstructured":"Huang YW, Vitetta ES . Immunotherapy of multiple myeloma Stem Cells 1995 13: 123\u2013134","journal-title":"Stem Cells"},{"key":"BF1702445_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3109\/10428199609093439","volume":"21","author":"R Powles","year":"1996","unstructured":"Powles R, Raje N, Horton C et al. Comparison of interferon tolerance after autologous bone marrow or peripheral blood stem cell transplants for myeloma patients who have responded to induction therapy Leuk Lymphoma 1996 21: 421\u2013427","journal-title":"Leuk Lymphoma"},{"key":"BF1702445_CR7","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1182\/blood.V92.9.3131","volume":"92","author":"JP Fermand","year":"1998","unstructured":"Fermand JP, Ravaud P, Chevret S et al. High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial Blood 1998 92: 3131\u20133136","journal-title":"Blood"},{"key":"BF1702445_CR8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1182\/blood.V85.2.588.588","volume":"85","author":"G Tricot","year":"1995","unstructured":"Tricot G, Jagannath S, Vesole D et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients Blood 1995 85: 588\u2013596","journal-title":"Blood"},{"key":"BF1702445_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1089\/scd.1.1996.5.339","volume":"5","author":"RM Lemoli","year":"1996","unstructured":"Lemoli RM, Cavo M, Fortuna A . Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma J Hematother 1996 5: 339\u2013349","journal-title":"J Hematother"},{"key":"BF1702445_CR10","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1182\/blood.V91.12.4489","volume":"91","author":"G Tricot","year":"1998","unstructured":"Tricot G, Gazitt Y, Leemhuis T et al. Collection, tumor contamination, and engraftment kinetics of highly purified hematopoietic progenitor cells to support high dose therapy in multiple myeloma Blood 1998 91: 4489\u20134495","journal-title":"Blood"},{"key":"BF1702445_CR11","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1056\/NEJM198405243102104","volume":"310","author":"B Barlogie","year":"1984","unstructured":"Barlogie B, Smith L, Alexanian R . Effective treatment of advanced multiple myeloma refractory to alkylating agents New Engl J Med 1984 310: 1353\u20131356","journal-title":"New Engl J Med"},{"key":"BF1702445_CR12","first-page":"17","volume":"1","author":"Force Committee of the Chronic Leukemia M","year":"1968","unstructured":"Committee of the Chronic Leukemia Myeloma Task Force, National Cancer Institute . Proposed guidelines for protocol studies. II. Plasma cell myeloma Cancer Chemother Rep 1968 1: 17\u201339","journal-title":"Cancer Chemother Rep"},{"key":"BF1702445_CR13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/0002-9343(77)90543-5","volume":"63","author":"Jr Case DC","year":"1977","unstructured":"Case DC Jr, Lee DJ III, Clarkson BD . Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol Am J Med 1977 63: 897\u2013903","journal-title":"Am J Med"},{"key":"BF1702445_CR14","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1561::AID-CNCR18>3.0.CO;2-W","volume":"79","author":"MM Oken","year":"1997","unstructured":"Oken MM, Harrington DP, Abramson N et al. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479 Cancer 1997 79: 1561\u20131567","journal-title":"Cancer"},{"key":"BF1702445_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Nonparametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"BF1702445_CR16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR . Regression models and life-tables JR Stat Soc [B] 1972 34: 187\u2013202","journal-title":"JR Stat Soc [B]"},{"key":"BF1702445_CR17","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1046\/j.1365-2141.1998.00930.x","volume":"102","author":"J Blad\u00e9","year":"1998","unstructured":"Blad\u00e9 J, Samson D, Reece D et al. (Myeloma Subcommittee of the EBMT (European Group for Blood and Marrow Transplant)). Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation BrJ Haematol 1998 102: 1115\u20131123","journal-title":"BrJ Haematol"},{"key":"BF1702445_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.7326\/0003-4819-122-4-199502150-00003","volume":"122","author":"HM Kantarjian","year":"1995","unstructured":"Kantarjian HM, Smith TL, O'Brien S et al . and the Leukemia Service Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-\u03b1 therapy Ann Intern Med 1995 122: 254\u2013261","journal-title":"Ann Intern Med"},{"key":"BF1702445_CR19","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S0140-6736(98)03030-X","volume":"352","author":"A Gratwohl","year":"1998","unstructured":"Gratwohl A, Hermans J, Goldman JM et al. for the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation Lancet 1998 352: 1087\u20131092","journal-title":"Lancet"},{"key":"BF1702445_CR20","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/S0140-6736(94)92589-5","volume":"343","author":"PB McGlave","year":"1994","unstructured":"McGlave PB, De Fabritiis P, Deisseroth A et al. Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups Lancet 1994 343: 1486\u20131488","journal-title":"Lancet"},{"key":"BF1702445_CR21","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","volume":"340","author":"CL Sawyers","year":"1999","unstructured":"Sawyers CL . Chronic myeloid leukemia New Engl J Med 1999 340: 1330\u20131340","journal-title":"New Engl J Med"},{"key":"BF1702445_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJM199501263320403","volume":"332","author":"RA Zittoun","year":"1995","unstructured":"Zittoun RA, Mandelli F, Willemze R et al . for the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia New Engl J Med 1995 332: 217\u2013223","journal-title":"New Engl J Med"},{"key":"BF1702445_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.7326\/0003-4819-102-3-285","volume":"102","author":"RE Champlin","year":"1985","unstructured":"Champlin RE, Ho WG, Gale RP et al. Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation vs consolidation chemotherapy Ann Intern Med 1985 102: 285\u2013291","journal-title":"Ann Intern Med"},{"key":"BF1702445_CR24","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1056\/NEJM199805213382104","volume":"338","author":"G Dighiero","year":"1998","unstructured":"Dighiero G, Maloum K, Desablens B et al . for the French Cooperative Group on Chronic Lymphocytic Leukemia Chlorambucil in indolent chronic lymphocytic leukemia New Engl J Med 1998 338: 1506\u20131514","journal-title":"New Engl J Med"},{"key":"BF1702445_CR25","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1182\/blood.V88.12.4711.bloodjournal88124711","volume":"88","author":"BB Bjorkstrand","year":"1996","unstructured":"Bjorkstrand BB, Ljungman P, Svensson H et al. Allogeneic bone marrow transplantation vs autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation Blood 1996 88: 4711\u20134718","journal-title":"Blood"},{"key":"BF1702445_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/sj.bmt.1701559","volume":"23","author":"MA Gertz","year":"1999","unstructured":"Gertz MA, Lacy MQ, Inwards DJ et al. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma Bone Marrow Transplant 1999 23: 221\u2013226","journal-title":"Bone Marrow Transplant"},{"key":"BF1702445_CR27","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/sj.bmt.1701805","volume":"23","author":"SV Rajkumar","year":"1999","unstructured":"Rajkumar SV, Fonseca R, Lacy MQ et al. Autologous stem cell transplantation for relapsed and primary refractory myeloma Bone Marrow Transplant 1999 23: 1267\u20131272","journal-title":"Bone Marrow Transplant"},{"key":"BF1702445_CR28","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/sj.bmt.1700738","volume":"19","author":"S Couban","year":"1997","unstructured":"Couban S, Stewart AK, Loach D et al. Autologous and allogeneic transplantation for multiple myeloma at a single centre Bone Marrow Transplant 1997 19: 783\u2013789","journal-title":"Bone Marrow Transplant"},{"key":"BF1702445_CR29","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1365-2141.1995.tb08378.x","volume":"89","author":"TE Witzig","year":"1995","unstructured":"Witzig TE, Gertz MA, Pineda AA et al. Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma Br J Haematol 1995 89: 640\u2013642","journal-title":"Br J Haematol"},{"key":"BF1702445_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1046\/j.1365-2141.1996.448987.x","volume":"93","author":"HM Prince","year":"1996","unstructured":"Prince HM, Imrie K, Sutherland DR et al. Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections Br J Haematol 1996 93: 142\u2013145","journal-title":"Br J Haematol"},{"key":"BF1702445_CR31","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1200\/JCO.1998.16.4.1554","volume":"16","author":"MJ Watts","year":"1998","unstructured":"Watts MJ, Sullivan AM, Leverett D et al. Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization J Clin Oncol 1998 16: 1554\u20131560","journal-title":"J Clin Oncol"},{"key":"BF1702445_CR32","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood.V88.3.838.838","volume":"88","author":"DH Vesole","year":"1996","unstructured":"Vesole DH, Tricot G, Jagannath S et al. Autotransplants in multiple myeloma: what have we learned? Blood 1996 88: 838\u2013847","journal-title":"Blood"},{"key":"BF1702445_CR33","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1182\/blood.V84.3.950.950","volume":"84","author":"DH Vesole","year":"1994","unstructured":"Vesole DH, Barlogie B, Jagannath S et al. High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants Blood 1994 84: 950\u2013956","journal-title":"Blood"},{"key":"BF1702445_CR34","first-page":"1091","volume":"7","author":"FM Stewart","year":"1993","unstructured":"Stewart FM . Indications and relative indications for stem cell transplantation in non-Hodgkin's lymphoma Leukemia 1993 7: 1091\u20131094","journal-title":"Leukemia"},{"key":"BF1702445_CR35","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood.V82.8.2324.bloodjournal8282324","volume":"82","author":"MA Dimopoulos","year":"1993","unstructured":"Dimopoulos MA, Alexanian R, Przepiorka D et al. Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma Blood 1993 82: 2324\u20132328","journal-title":"Blood"},{"key":"BF1702445_CR36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood.V88.1.289.289","volume":"88","author":"D Billadeau","year":"1996","unstructured":"Billadeau D, Van Ness B, Kimlinger T et al. Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma Blood 1996 88: 289\u2013296","journal-title":"Blood"},{"key":"BF1702445_CR37","first-page":"723","volume":"17","author":"RJ Johnson","year":"1996","unstructured":"Johnson RJ, Owen RG, Smith GM et al. Peripheral blood stem cell transplantation in myeloma using CD34 selected cells Bone Marrow Transplant 1996 17: 723\u2013727","journal-title":"Bone Marrow Transplant"},{"key":"BF1702445_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10428199709058595","volume":"26","author":"RM Lemoli","year":"1997","unstructured":"Lemoli RM, Fortuna A, Raspadori D et al. Selection and transplantation of autologous hematopoietic CD34+ cells for patients with multiple myeloma Leuk Lymphoma 1997 26: (Suppl. 1) 1\u201311","journal-title":"Leuk Lymphoma"},{"key":"BF1702445_CR39","first-page":"714a (Abstr.)","volume":"94","author":"AK Stewart","year":"1999","unstructured":"Stewart AK, Schiller G, Vescio R et al. CD34 selection does not prolong disease free or overall survival in myeloma patients undergoing autologous stem cell transplant: results of a phase III study Blood 1999 94: (Suppl. 1) 714a (Abstr.)","journal-title":"Blood"},{"key":"BF1702445_CR40","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1182\/blood.V80.3.733.733","volume":"80","author":"R Bataille","year":"1992","unstructured":"Bataille R, Boccadoro M, Klein B et al. C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system Blood 1992 80: 733\u2013737","journal-title":"Blood"},{"key":"BF1702445_CR41","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood.V93.7.2411","volume":"93","author":"VL Reichardt","year":"1999","unstructured":"Reichardt VL, Okada CY, Liso A et al. Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma \u2013 a feasibility study Blood 1999 93: 2411\u20132419","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702445","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T11:19:40Z","timestamp":1733570380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,7,1]]}},"alternative-id":["BF1702445"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702445","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2000,7,1]]},"assertion":[{"value":"20 December 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}